Search
Interviews with the world’s key opinion leaders in cancer
Francesc Solé

Genetic change detection: key for selecting best therapy for older patients with myelodysplastic syndrome

April 4, 2011
Francesc Solé
AudioMedica News
Genetic change detection: key for selecting best therapy for older patients with myelodysplastic syndrome
Loading
/
Francesc Solé
Francesc Solé

ROME—Testing for the genetic changes predicting prognosis is a key method for choosing the right therapy for your elderly patient with myelodysplastic syndrome according to Francesc Solé, Chief of the Laboratory of Cytogenetics at the Hospital del Mar in Barcelona. He tells ecancer radio about the importance of using gene tests to help define risk in older patients.



LISTEN

[audio:https://www.audiomedica.com/podcasting/ecancer/110326FrancescSolePODCASTLoRes.mp3]

Further reading

Menu